Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CervoMed Inc. - Common Stock (NQ:CRVO)

9.050 -0.430 (-4.54%)
Streaming Delayed Price Updated: 12:53 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CervoMed Inc. - Common Stock

< Previous 1 2 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Keep an eye on the top gainers and losers in Wednesday's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Peering Into CervoMed's Recent Short Interest
Via Benzinga
On Monday, there are stocks with unusual volume. Let's take a look.
On Monday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
On Friday, there are stocks with unusual volume. Let's take a look.
Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
Unusual volume stocks in Thursday's session
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
CervoMed's Dementia Study's 16-Week Data 'Compelling Enough To Move From Sidelines' Analyst Says
CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and increased confidence in the drug. 
Via Benzinga
Top movers in Thursday's pre-market session
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
Top movers in Wednesday's session
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
These stocks are the most active in today's session
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention. 
Via Chartmill
Which stocks are experiencing notable movement on Wednesday?
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Top Biotech Short Squeeze Stocks
Investing in biotechnology stocks offers a unique opportunity for individuals looking to gain exposure to one of the most dynamic and innovative sectors of the market. 
Via Talk Markets
Topics Stocks / Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings
Via Benzinga
CervoMed's Dementia Candidate Fails In Mid-Stage Study, Stock Plummets
CervoMed reports RewinD-LB trial results for neflamapimod in dementia with Lewy bodies, highlighting missed endpoints and upcoming data timelines. 
Via Benzinga
US Small Business Optimism Hits 3-Year High As Election Results 'Signal A Major Shift'
Small businesses are entering the holiday season with newfound confidence and momentum, thanks to post-election policies and reduced inflation. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.